주식/증권
📈 긍정적
NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up
요약
NeuroPace's Q2 revenues rise 17.1% as RNS demand strengthens, while a narrower loss and higher 2026 outlook highlight continued momentum.